Drug Type Chemical drugs |
Synonyms- |
Target |
Action modulators |
Mechanism PGRN modulators(Progranulin modulators) |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Alzheimer Disease | Preclinical | United States | 04 Aug 2024 | |
| Amyotrophic Lateral Sclerosis | Preclinical | United States | 04 Aug 2024 |





